An Anti–glypican 3/Cd3 Bispecific T Cell–redirecting Antibody for Treatment of Solid Tumors
Science Translational Medicine - United States
doi 10.1126/scitranslmed.aal4291
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 4, 2017
Authors
Publisher
American Association for the Advancement of Science (AAAS)